Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference21 articles.
1. Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer;Iwamoto;J Natl Cancer Inst,2011
2. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer;Denkert;J Clin Oncol,2010
3. Subtype-specific metagene-based prediction of outcome after neoadjuvant and adjuvant treatment in breast cancer;Callari;Clin Cancer Res,2016
4. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients;Herbst;Nature,2014
5. Platinum-based chemotherapy in metastatic breast cancer: current status;Decatris;Cancer Treat Rev,2004
Cited by 113 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancer;Immunotherapy;2024-03
2. Development of a machine learning-based radiomics signature for estimating breast cancer TME phenotypes and predicting anti-PD-1/PD-L1 immunotherapy response;Breast Cancer Research;2024-01-29
3. Low‐Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial Cells;Advanced Science;2024-01-08
4. Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?;Current Oncology Reports;2024-01-02
5. Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials;The Lancet Oncology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3